Chang Gung Medical Foundation-Linkou, Urinary Oncology
Taoyuan, Taiwan
Hospital in Taoyuan City
No. 5, Fuxing St, Guishan District, Taoyuan City, 333
About Chang Gung Medical Foundation-Linkou, Urinary Oncology
The Linkou Chang Gung Memorial Hospital also known as Chang Gung Memorial Hospital or "Chang Gung Hospital", is a hospital located in Guishan District, Taoyuan City, Taiwan. It is part of the Chang Gung Medical Foundation hospital network.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Pfizer
2
Clinical Trials at Chang Gung Medical Foundation-Linkou, Urinary Oncology
During the past decade, Chang Gung Medical Foundation-Linkou, Urinary Oncology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)
2015-05-20
2021-12-13
Completed
915
A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)
2015-12-21
2022-07-12
Completed
566
Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)
2016-05-19
2019-05-16
Terminated
998
Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
2016-06-30
2023-06-30
Active, not recruiting
1,214
A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract
2016-11-30
2022-12-12
Completed
1,005
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
2017-01-03
2022-12-08
Completed
778
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Chang Gung Medical Foundation-Linkou, Urinary Oncology
According to Clinical.Site data, the most researched conditions in "Chang Gung Medical Foundation-Linkou, Urinary Oncology" are
"Ovarian Cancer" (2 trials), "Renal Cell Carcinoma" (2 trials), "Urinary Tract Cancer" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "Chang Gung Medical Foundation-Linkou, Urinary Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Chang Gung Medical Foundation-Linkou, Urinary Oncology
Most popular intervention types in "Chang Gung Medical Foundation-Linkou, Urinary Oncology" are "Drug" (6 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Placebo" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials), "Avelumab" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Chang Gung Medical Foundation-Linkou, Urinary Oncology
The vast majority of trials in "Chang Gung Medical Foundation-Linkou, Urinary Oncology" are
4 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Chang Gung Medical Foundation-Linkou, Urinary Oncology
Currently, there are NaN active trials in "Chang Gung Medical Foundation-Linkou, Urinary Oncology".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Chang Gung Medical Foundation-Linkou, Urinary Oncology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Chang Gung Medical Foundation-Linkou, Urinary Oncology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".